Bulletin de Périodique
Addiction , Vol.116, n°11 - November 2021
Paru le :
01/11/2021
Année :
2021
Page(s) :
2933-3270
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- What can we learn from the history of research on psychedelic drugs in the addictions? [Editorial]. Hall W., Farrell M., p. 2936-2938.
- Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries [Addiction Opinion and Debate]. Adams P.J., Rychert M., Wilkins C., p. 2939-2946.
- Think big about developing the science. McCambridge J., Madden M., p. 2947-2948.
- We can't rely upon monitoring by researchers and civil society to prevent cannabis industry influence-a global response is needed. Casswell S., p. 2948-2950.
- Cannabis chains of influence from a US perspective. Jernigan D.H., p. 2950-2951.
- How does the influence of the cannabis industry differ from that of alcohol and tobacco? Adams P.J., Rychert M., Wilkins C., p. 2951-2952.
- Social norms as a predictor of smoking uptake among youth: a systematic review, meta-analysis and meta-regression of prospective cohort studies. East K., McNeill A., Thrasher J.F., Hitchman S.C., p. 2953-2967.
- A meta-analysis of problem gambling risk factors in the general adult population. Allami Y., Hodgins D.C., Young M., Brunelle N., Currie S., Dufour M., et al., p. 2968-2977.
- Supporting smoking cessation and preventing relapse following a stay in a smoke-free setting: a meta-analysis and investigation of effective behaviour change techniques. Shoesmith E., Huddlestone L., Lorencatto F., Shahab L., Gilbody S., Ratschen E., p. 2978-2994.
- Associations between social media usage and alcohol use among youths and young adults: findings from Understanding Society. Ng Fat L., Cable N., Kelly Y., p. 2995-3005.
- Commentary on Ng Fat et al.: On-line interaction and behavior IRL-social media and alcohol use among young people. Savolainen I., p. 3006-3007.
- A longitudinal study of the moderating effects of romantic relationships on the associations between alcohol use and trauma in college students. Smith R.L., Dick D.M., Amstadter A., Thomas N., Salvatore J.E., p. 3008-3018.
- The correlates and extent of prescribing of medications for alcohol relapse prevention in England. Donoghue K., p. 3019-3026.
- Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact. Morley K.C., p. 3027-3028.
- Acute effect of alcohol on working memory updating. Cofresi R.U., Watts A.L., Martins J.S., Wood P.K., Sher K.J., Cowan N., et al., p. 3029-3043.
- The impact of removing former drinkers from genome-wide association studies of AUDIT-C. Dao C., Zhou H., Small A., Gordon K.S., Li B., Kember R.L., et al., p. 3044-3054.
- The validity of the state-trait anxiety inventory and the brief scale for anxiety in an inpatient sample with alcohol use disorder. Shah N.N., Schwandt M.L., Hobden B., Baldwin D.S., Sinclair J., Agabio R., et al., p. 3055-3068.
- The associations between prenatal cannabis use disorder and neonatal outcomes. Shi Y., Zhu B., Liang D., p. 3069-3079.
- Commentary on Shi et al: Prenatal cannabis use and infant health - the search for clarity and consistency. Hwang S.S., p. 3080-3081.
- Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference-in-differences analysis of a pay-for-performance scheme in England. Mason T., Whittaker W., Jones A., Sutton M., p. 3082-3093.
- Trends in MDMA-related mortality across four countries. Roxburgh A., Sam B., Kriikku P., Mounteney J., Castanera A., Dias M., et al., p. 3094-3103.
- Does the preparation for intravenous administration affect the composition of heroin injections? A controlled laboratory study. Andersen J.M., Bogen I.L., Karinen R., Brochmann G.W., Morland J., Vindenes V., et al., p. 3104-3112.
- Commentary on Andersen et al.: Time for drug checking for heroin users? Scott J., Henderson G., p. 3113-3114.
- The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial. van Santen D.K., Boyd A., Matser A., Maher L., Hickman M., Lodi S., et al., p. 3115-3126.
- All-cause and suicide mortality among people with methamphetamine use disorder: a nation-wide cohort study in Taiwan. Lee W.C., Chang H.M., Huang M.C., Pan C.H., Su S.S., Tsai S.Y., et al., p. 3127-3138.
- The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Bharat C., Larney S., Barbieri S., Dobbins T., Jones N.R., Hickman M., et al., p. 3139-3152.
- Maternal and child genetic liability for smoking and caffeine consumption and child mental health: an intergenerational genetic risk score analysis in the ALSPAC cohort. Schellhas L., Haan E., Easey K.E., Wootton R.E., Sallis H.M., Sharp G.C., et al., p. 3153-3166.
- Evaluating four motivation-phase intervention components for use with primary care patients unwilling to quit smoking: a randomized factorial experiment. Cook J.W., Baker T.B., Fiore M.C., Collins L.M., Piper M.E., Schlam T.R., et al., p. 3167-3179.
- Who, me? Optimism bias about US teenagers' ability to quit vaping. Strombotne K., Sindelar J., Buckell J., p. 3180-3187.
- Community-based smoking cessation treatment for adults with high anxiety sensitivity: a randomized clinical trial. Smits J.A.J., Zvolensky M.J., Rosenfield D., Brown R.A., Otto M.W., Dutcher C.D., et al., p. 3188-3197.
- Attributable fractions for substance use in relation to crime. Young M.M., De Moor C., Kent P., Stockwell T., Sherk A., Zhao J., et al., p. 3198-3205.
- Moderators and mediators of outcomes of parents with substance use problems: further evaluation of the Parents under Pressure programme. Dawe S., Harnett P., Gullo M.J., Eggins E., Barlow J., p. 3206-3218.
- The shape of gambling risk-curves for frequency, expenditure and proportion of income in Australia. Greenwood C.J., Youssef G.J., Merkouris S.S., Dowling N.A., p. 3219-3226.
- The relationship between cannabis and schizophrenia: a genetically informed perspective. Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R., Murray R.M., Edenberg H.J., et al., p. 3227-3234.
- Illicit drug use and oral health. Rossow I., p. 3235-3242.
- Raising the bar: improving methodological rigour in cognitive alcohol research. Pennington C.R., Jones A., Bartlett J.E., Copeland A., Shaw D.J., p. 3243-3251.
- Coordination, framing and innovation: the political sophistication of public health advocates in Ireland. Lesch M., McCambridge J., p. 3252-3260.
- 'A man can only be truly known in drunkenness and war.' An anthropological perspective on alcohol use during the Portuguese Colonial War. Gil Calado V., p. 3261-3268.
- Raising awareness of cannabis detrimental pulmonary consequences. Ortiz Bonilla M., Rodriguez W., p. 3269.
- What can we learn from the history of research on psychedelic drugs in the addictions? [Editorial]. Hall W., Farrell M., p. 2936-2938.
- Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries [Addiction Opinion and Debate]. Adams P.J., Rychert M., Wilkins C., p. 2939-2946.
- Think big about developing the science. McCambridge J., Madden M., p. 2947-2948.
- We can't rely upon monitoring by researchers and civil society to prevent cannabis industry influence-a global response is needed. Casswell S., p. 2948-2950.
- Cannabis chains of influence from a US perspective. Jernigan D.H., p. 2950-2951.
- How does the influence of the cannabis industry differ from that of alcohol and tobacco? Adams P.J., Rychert M., Wilkins C., p. 2951-2952.
- Social norms as a predictor of smoking uptake among youth: a systematic review, meta-analysis and meta-regression of prospective cohort studies. East K., McNeill A., Thrasher J.F., Hitchman S.C., p. 2953-2967.
- A meta-analysis of problem gambling risk factors in the general adult population. Allami Y., Hodgins D.C., Young M., Brunelle N., Currie S., Dufour M., et al., p. 2968-2977.
- Supporting smoking cessation and preventing relapse following a stay in a smoke-free setting: a meta-analysis and investigation of effective behaviour change techniques. Shoesmith E., Huddlestone L., Lorencatto F., Shahab L., Gilbody S., Ratschen E., p. 2978-2994.
- Associations between social media usage and alcohol use among youths and young adults: findings from Understanding Society. Ng Fat L., Cable N., Kelly Y., p. 2995-3005.
- Commentary on Ng Fat et al.: On-line interaction and behavior IRL-social media and alcohol use among young people. Savolainen I., p. 3006-3007.
- A longitudinal study of the moderating effects of romantic relationships on the associations between alcohol use and trauma in college students. Smith R.L., Dick D.M., Amstadter A., Thomas N., Salvatore J.E., p. 3008-3018.
- The correlates and extent of prescribing of medications for alcohol relapse prevention in England. Donoghue K., p. 3019-3026.
- Commentary on Donoghue: Low prescribing rates of pharmacotherapy for alcohol use disorder limit potential public health impact. Morley K.C., p. 3027-3028.
- Acute effect of alcohol on working memory updating. Cofresi R.U., Watts A.L., Martins J.S., Wood P.K., Sher K.J., Cowan N., et al., p. 3029-3043.
- The impact of removing former drinkers from genome-wide association studies of AUDIT-C. Dao C., Zhou H., Small A., Gordon K.S., Li B., Kember R.L., et al., p. 3044-3054.
- The validity of the state-trait anxiety inventory and the brief scale for anxiety in an inpatient sample with alcohol use disorder. Shah N.N., Schwandt M.L., Hobden B., Baldwin D.S., Sinclair J., Agabio R., et al., p. 3055-3068.
- The associations between prenatal cannabis use disorder and neonatal outcomes. Shi Y., Zhu B., Liang D., p. 3069-3079.
- Commentary on Shi et al: Prenatal cannabis use and infant health - the search for clarity and consistency. Hwang S.S., p. 3080-3081.
- Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference-in-differences analysis of a pay-for-performance scheme in England. Mason T., Whittaker W., Jones A., Sutton M., p. 3082-3093.
- Trends in MDMA-related mortality across four countries. Roxburgh A., Sam B., Kriikku P., Mounteney J., Castanera A., Dias M., et al., p. 3094-3103.
- Does the preparation for intravenous administration affect the composition of heroin injections? A controlled laboratory study. Andersen J.M., Bogen I.L., Karinen R., Brochmann G.W., Morland J., Vindenes V., et al., p. 3104-3112.
- Commentary on Andersen et al.: Time for drug checking for heroin users? Scott J., Henderson G., p. 3113-3114.
- The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial. van Santen D.K., Boyd A., Matser A., Maher L., Hickman M., Lodi S., et al., p. 3115-3126.
- All-cause and suicide mortality among people with methamphetamine use disorder: a nation-wide cohort study in Taiwan. Lee W.C., Chang H.M., Huang M.C., Pan C.H., Su S.S., Tsai S.Y., et al., p. 3127-3138.
- The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study. Bharat C., Larney S., Barbieri S., Dobbins T., Jones N.R., Hickman M., et al., p. 3139-3152.
- Maternal and child genetic liability for smoking and caffeine consumption and child mental health: an intergenerational genetic risk score analysis in the ALSPAC cohort. Schellhas L., Haan E., Easey K.E., Wootton R.E., Sallis H.M., Sharp G.C., et al., p. 3153-3166.
- Evaluating four motivation-phase intervention components for use with primary care patients unwilling to quit smoking: a randomized factorial experiment. Cook J.W., Baker T.B., Fiore M.C., Collins L.M., Piper M.E., Schlam T.R., et al., p. 3167-3179.
- Who, me? Optimism bias about US teenagers' ability to quit vaping. Strombotne K., Sindelar J., Buckell J., p. 3180-3187.
- Community-based smoking cessation treatment for adults with high anxiety sensitivity: a randomized clinical trial. Smits J.A.J., Zvolensky M.J., Rosenfield D., Brown R.A., Otto M.W., Dutcher C.D., et al., p. 3188-3197.
- Attributable fractions for substance use in relation to crime. Young M.M., De Moor C., Kent P., Stockwell T., Sherk A., Zhao J., et al., p. 3198-3205.
- Moderators and mediators of outcomes of parents with substance use problems: further evaluation of the Parents under Pressure programme. Dawe S., Harnett P., Gullo M.J., Eggins E., Barlow J., p. 3206-3218.
- The shape of gambling risk-curves for frequency, expenditure and proportion of income in Australia. Greenwood C.J., Youssef G.J., Merkouris S.S., Dowling N.A., p. 3219-3226.
- The relationship between cannabis and schizophrenia: a genetically informed perspective. Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R., Murray R.M., Edenberg H.J., et al., p. 3227-3234.
- Illicit drug use and oral health. Rossow I., p. 3235-3242.
- Raising the bar: improving methodological rigour in cognitive alcohol research. Pennington C.R., Jones A., Bartlett J.E., Copeland A., Shaw D.J., p. 3243-3251.
- Coordination, framing and innovation: the political sophistication of public health advocates in Ireland. Lesch M., McCambridge J., p. 3252-3260.
- 'A man can only be truly known in drunkenness and war.' An anthropological perspective on alcohol use during the Portuguese Colonial War. Gil Calado V., p. 3261-3268.
- Raising awareness of cannabis detrimental pulmonary consequences. Ortiz Bonilla M., Rodriguez W., p. 3269.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection![Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries [Addiction Opinion and Debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_84391.webp)
P. J. ADAMS ;
M. RYCHERT ;
C. WILKINS
|
2021
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
BACKGROUND AND AIM: New Zealand has recently legalized medicinal cannabis and has explored the possibility of legalizing large-scale recreational cannabis supply. In the process, concerns have emerged regarding whether corporations involved in t[...]

K. EAST ;
A. McNEILL ;
J. F. THRASHER ;
S. C. HITCHMAN
|
2021
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
BACKGROUND AND AIMS: Social norms towards smoking are a key concept in tobacco control policy and research. However, the influence and strength of different types of social norms on youth smoking uptake is unclear. This study aimed to examine, q[...]

Y. ALLAMI ;
D. C. HODGINS ;
M. YOUNG ;
N. BRUNELLE ;
S. CURRIE ;
M. DUFOUR ;
M. C. FLORES-PAJOT ;
L. NADEAU
|
2021
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
BACKGROUND AND AIMS: Few meta-analyses have been conducted to pool the most constant risk factors for problem gambling. The present meta-analysis summarizes effect sizes of the most frequently assessed problem gambling risk factors, ranks them a[...]

A. ROXBURGH ;
B. SAM ;
P. KRIIKKU ;
J. MOUNTENEY ;
A. CASTANERA ;
M. DIAS ;
I. GIRAUDON
|
2021
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
Dans Addiction (Vol.116, n°11, November 2021) Article : Périodique
AIMS: To determine trends in 3,4 methylenedioxymethamphetamine (MDMA)-related death rates across Australia, Finland, Portugal and Turkey and to analyse the toxicology and causes of death across countries.
DESIGN: Analysis of MDMA-related deaths[...]